Citations

Clear

6273 citation(s) found for "To, Andrew".

Transcutaneous Spinal Cord Stimulation and its Impact on Cardiovascular Autonomic Regulation after Spinal Cord Injury
Tuthill, Christopher, Solinsky, Ryan , Burns, Kathryn , Tuthill, Christopher , Taylor, J Andrew , Solinsky, Ryan , Burns, Kathryn, Tuthill, Christopher, Hamner, Jason W. , Taylor, J. Andrew

Mayo Clinic

American Journal of Physiology-Heart and Circulatory Physiology | November 10, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1152/ajpheart.00588.2023 | PMID 37947438 Get It

Individuals with spinal cord injury (SCI) have significant dysfunction in cardiovascular autonomic regulation. While recent findings postulate that spinal cord stimulation improves autonomic regulation, limited scope of past methods have tested only above level sympathetic activation, leaving significant uncertainty. To identify whether transcutaneous spinal cord stimulation improves cardiovascular autonomic regulation, two pairs of well-matched individuals with and without high-thoracic, complete SCI were recruited. Baseline autonomic regulation was characterized with multiple tests of sympathoinhibition and above/below injury level sympathoexcitation. At three subsequent visits, testing was repeated with the addition sub-motor threshold transcutaneous spinal cord stimulation at three previously advocated frequencies. Uninjured controls demonstrated no autonomic deficits at baseline and had no changes with any frequency of stimulation. As expected, individuals with SCI had baseline autonomic dysfunction. In a frequency-dependent manner, spinal cord stimulation enhanced sympathoexcitatory responses, normalizing previously impaired Valsalva's maneuvers. However, stimulation exacerbated already impaired sympathoinhibitory responses, resulting in significantly greater mean arterial pressure increases with the same phenylephrine doses compared to baseline. Impaired sympathoexcitatory response below the level of injury were also further exacerbated with spinal cord stimulation. At baseline, neither individual with SCI demonstrated autonomic dysreflexia with the noxious foot cold pressor test; the addition of stimulation led to a dysreflexic response in every trial, with greater relative hypertension and bradycardia indicating no improvement in cardiovascular autonomic regulation. Collectively, transcutaneous spinal cord stimulation demonstrates no improvements in autonomic regulation after SCI, and instead likely generates tonic sympathoexcitation which may lower the threshold for dangerous autonomic dysreflexia.
Incidence of Post-ERCP Pancreatitis in Patients Receiving Diclofenac Versus Indomethacin Prophylaxis
Yamparala, A., Sathi, Thanmay, Harmsen, William S. , Lemke, Emily, Dayyeh, Barham Abu, Bofill-García, Aliana, Martin, John A. , Petersen, Bret T. , Topazian, Mark , Chandrasekhara, V., Law, Ryan , Janssens, Laurens , Lemke, E., Lévy, Michaël , Petersen, Bret T. , Storm, Andrew C. , Valls, E. Vargas

Mayo Clinic

Endoscopy | November 9, 2023 | Volume: 55 | Issue: S 02 | Pages: S156-S156

10.1055/s-0043-1765392 Get It

Clinician Perspectives Regarding the Impact of Information Technology on Multidisciplinary Tumor Boards: A National Comprehensive Cancer Network Survey
Arafat, Waddah , Wagner, Andrew J. , Osterman, Travis , Martin, Daniel , Sugalski, Jessica , Heinrichs, Tricia , Racz, Jennifer M. , Tevaarwerk, Amyé , Wagner, Andrew J , Osterman, Travis , Martin, Daniel B , Sugalski, Jessica , Heinrichs, Tricia , Racz, Jennifer , Tevaarwerk, Amye J , Fu, Paul C.

Mayo Clinic

JCO Clinical Cancer Informatics | November 9, 2023 | Volume: No volume available | Issue: 7 | Pages: No page available

10.1200/cci.23.00056 | PMID 37944060 Get It

PURPOSE Multidisciplinary tumor boards (MTBs) support high-quality cancer care. Little is known about the impact of information technology (IT) tools on the operational and technical aspects of MTBs. The National Comprehensive Cancer Network EHR Oncology Advisory Group formed a workgroup to investigate the impact of IT tools such as EHRs and virtual conferencing on MTBs. METHODS The workgroup created a cross-sectional survey for oncology clinicians (eg, pathology, medical, surgical, radiation, etc) participating in MTBs at 31 National Comprehensive Cancer Network member institutions. A standard invitation e-mail was shared with each EHR Advisory Group Member with a hyperlink to the survey, and each member distributed the survey to MTB participants at their institution or identified the appropriate person at their institution to do so. The survey was open from February 26, 2022, to April 26, 2022. Descriptive statistics were applied in the analysis of responses, and a qualitative thematic analysis of open-ended responses was completed. RESULTS Individuals from 27 institutions participated. Almost all respondents (99%, n = 764 of 767) indicated that their MTBs had participants attending virtually. Most indicated increased attendance (69%, n = 514 of 741) after virtualization with the same or improved quality of discussion (75%, n = 557 of 741) compared with in-person MTBs. Several gaps between the current and ideal state emerged regarding EHR integration: 57% (n = 433 of 758) of respondents noted the importance of adding patients for MTB presentation via the EHR, but only 40% (n = 302 of 747) reported being able to do so most of the time. Similarly, 87% (n = 661 of 760) indicated the importance of documenting recommendations in the EHR, but only 53% (n = 394 of 746) reported this occurring routinely. CONCLUSION Major gaps include the lack of EHR integration for MTBs. Clinical workflows and EHR functionalities could be improved to further optimize EHRs for MTB management and documentation.
Utilisation of cardiovascular preventive services in a rheumatoid arthritis population-based cohort
Montes, Daniel , Hulshizer, Cassondra A., Myasoedova, Elena , Hanson, Andrew C. , Figueroa‐Parra, Gabriel , Crowson, Cynthia S. , Figueroa-Parra, Gabriel , Crowson, CS , Myasoedova, Elena , Davis, John M. , Duarte‐García, Alí , Chevet, Baptiste

Mayo Clinic

RMD Open | November 9, 2023 | Volume: 9 | Issue: 4 | Pages: e003318

10.1136/rmdopen-2023-003318 | PMID 37945289 Get It

Objectives The objective is to examine utilisation of cardiovascular preventive services in patients with rheumatoid arthritis (RA), compared with a non-RA population, and to examine cardiovascular disease (CVD) screening rates among RA patients without diabetes mellitus (DM), hypertension or hyperlipidaemia to non-RA patients with one of these diagnoses. Methods All ≥18-year-old patients with an RA diagnosis living in one of eight Minnesota counties on 1 January 2015 were included and matched (1:1) by sex, age and county to non-RA comparators. Rates of screening for CVD risk factors, including DM (ie, glucose), hypertension (ie, blood pressure) and hyperlipidaemia (ie, lipids), were compared between groups using Cox models. Results The study included 1614 patients with RA and 1599 non-RA comparators. DM screening was more common among patients with RA (HR: 1.10, 95% CI: 1.01 to 1.19), as was hypertension screening (HR: 1.37, 95% CI: 1.24 to 1.52). Hyperlipidaemia screening in RA was similar to comparators (HR: 0.99, 95% CI: 0.89 to 1.10). Conversely, patients with RA and no CVD risk factors had a lower probability of undergoing diabetes (HR: 0.67, 95% CI: 0.57 to 0.78) and hyperlipidaemia screening (HR: 0.65, 95% CI: 0.54 to 0.79) than non-RA patients with only one CVD risk factor diagnosis. Hypertension screening was similar between both groups. Conclusions RA patients undergo CVD preventive screening at rates at least comparable to the general population. However, patients with RA as their sole CVD risk factor were less likely to undergo screenings, despite an equivalent-to-higher risk as the traditional CVD risk factors. These findings demonstrate opportunities for improvement of RA patient care.
Staged Intracranial Free Tissue Transfer and Cranioplasty for a Refractory Nasal-cranial Base Fistula
Emanuels, Andrew F., Cherukuri, Sai , Stokken, Janalee K., Emanuels, Andrew, Gompel, Jamie J. Van , Mardini, Samir , Gibreel, Waleed

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | November 9, 2023 | Volume: 11 | Issue: 11 | Pages: e5392

10.1097/gox.0000000000005392 | PMID 37954215 Get It

Summary: After a transnasal endoscopic resection of a high-grade adenoid cystic carcinoma that underwent adjuvant chemoradiation, there was delayed recurrence managed by en bloc resection through an open craniofacial approach. Subsequently, the patient developed a chronic nasocranial fistula with secondary infection and bone flap resorption. This resulted in infectious episodes with secondary scalp incisional dehiscence and hardware exposure which required multiple bone debridement procedures, hardware removal, prolonged IV antibiotics, and hyperbaric oxygen treatment. The nasocranial fistula and chronic frontal bone osteomyelitis persisted despite the previous interventions. The patient underwent a frontal bone removal and obliteration of the anterior cranial base fistula with a free vastus lateralis muscle flap. At 4 weeks postoperatively, the intranasal portion of the muscle flap had completely mucosalized. After a 6-week course of IV antibiotics, a secondary cranioplasty using a custom-made poly-ether-ether-ketone implant was performed. The patient remained disease- and infection-free for the duration of follow-up (17 months).
Predictors of Respiratory Failure Development in a Multicenter Cohort of Inpatients With Cirrhosis
Bajaj, Jasmohan S. , Kamath, Patrick S. , Reddy, K. Rajender , Keaveny, Andrew P. , Duarte‐Rojo, Andrés , Kappus, Matthew R. , Verna, Elizabeth C. , Biggins, Scott W. , Vargas, Hugo E. , Shaw, Jawaid , Dahiya, Monica , Filipek, Natalia, Wegermann, Kara , Cabello, Ricardo , Bera, Chinmay , Thuluvath, Paul J. , Keaveny, Andrew P , Duarte-Rojo, Andres , Kappus, Matthew R , Albhaisi, Somaya , Fallahzadeh, Mohammad Amin , Wegermann, Kara , Bera, Chinmay , BUSH, BRIAN J. , Thacker, Leroy R , Wong, Florence , Vargas, Hugo E , Asrani, Sumeet K. , Tandon, Puneeta , Albhaisi, Somaya , Thacker, Leroy R. , Wong, Florence

Mayo Clinic

American Journal of Gastroenterology | November 8, 2023 | Volume: 119 | Issue: 4 | Pages: 712-718

10.14309/ajg.0000000000002574 | PMID 37938163 Get It

INTRODUCTION: Hospitalized patients with cirrhosis can develop respiratory failure (RF), which is associated with a poor prognosis, but predisposing factors are unclear. METHODS: We prospectively enrolled a multicenter North American cirrhosis inpatient cohort and collected admission and in-hospital data (grading per European Association for the Study of Liver-Chronic Liver Failure scoring system, acute kidney injury [AKI], infections [admission/nosocomial], and albumin use) in an era when terlipressin was not available in North America. Multivariable regression to predict RF was performed using only admission day and in-hospital events occurring before RF. RESULTS: A total of 511 patients from 14 sites (median age 57 years, admission model for end-stage liver disease [MELD]-Na 23) were enrolled: RF developed in 15%; AKI occurred in 24%; and 11% developed nosocomial infections (NI). At admission, patients who developed RF had higher MELD-Na, gastrointestinal (GI) bleeding/AKI-related admission, and prior infections/ascites. During hospitalization, RF developers had higher NI (especially respiratory), albumin use, and other organ failures. RF was higher in patients receiving albumin (83% vs 59%, P < 0.0001) with increasing doses (269.5 ± 210.5 vs 208.6 ± 186.1 g, P = 0.01) regardless of indication. Admission for AKI, GI bleeding, and high MELD-Na predicted RF. Using all variables, NI (odds ratio [OR] = 4.02, P = 0.0004), GI bleeding (OR = 3.1, P = 0.002), albumin use (OR = 2.93, P = 0.01), AKI (OR = 3.26, P = 0.008), and circulatory failure (OR = 3.73, P = 0.002) were associated with RF risk. DISCUSSION: In a multicenter inpatient cirrhosis study of patients not exposed to terlipressin, 15% of patients developed RF. RF risk was highest in those admitted with AKI, those who had GI bleeding on admission, and those who developed NI and other organ failures or received albumin during their hospital course. Careful volume monitoring and preventing nosocomial respiratory infections and renal or circulatory failures could reduce this risk.
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023
Advani, Ranjana H. , Andreadis, B., Chang, Julie , Christian, Beth , deVos, Sven, Fayad, Luis , Hamid, Muhammad Saad , Hernandez‐Ilizaliturri, Francisco J. , Kaminski, Mark , Karimi, Yasmin , King, Rebecca L. , Krivacic, Susan, LaCasce, Ann S. , Messmer, Marcus , Narkhede, Mayur , Rabinovitch, Rachel , Roberts, Kenneth B. , Smith, Stephen D. , Svoboda, Jakub , Swinnen, Lode J., Tuscano, Joseph M. , Dwyer, Mary A., Sundar, Hema, Advani, Ranjana H , Karimi, Yasmin H , Zelenetz, Andrew D. , Gordon, Leo I. , Abramson, Jeremy S. , Bartlett, Nancy L. , Budde, Lihua E. , Caimi, Paolo F. , Dholaria, Bhagirathbhai , Habermann, Thomas M. , Hu, Boyu , Kelsey, Chris R. , Lim, Megan S. , Ramakrishnan, Praveen , Reid, Erin G , Saeed, Hayder , Vose, Julie M.

Mayo Clinic

Journal of the National Comprehensive Cancer Network | November 7, 2023 | Volume: 21 | Issue: 11 | Pages: 1118-1131

10.6004/jnccn.2023.0057 | PMID 37935098 Get It

Novel targeted therapies (small molecule inhibitors, antibody–drug conjugates, and CD19-directed therapies) have changed the treatment landscape of relapsed/refractory B-cell lymphomas. Bruton’s tyrosine kinase (BTK) inhibitors continue to evolve in the management of mantle cell lymphoma (MCL), in both the relapsed/refractory and the frontline setting. Anti-CD19 CAR T-cell therapies are now effective and approved treatment options for relapsed/refractory follicular lymphoma (FL), diffuse large B-cell lymphoma (DLBCL), and MCL. Bispecific T-cell engagers represent a novel immunotherapeutic approach for relapsed FL and DLBCL after multiple lines of therapies, including prior CAR T-cell therapy. These NCCN Guideline Insights highlight the significant updates to the NCCN Guidelines for B-Cell Lymphomas for the treatment of FL, DLBCL, and MCL.
Development and validation of a model to predict acute kidney injury following high‐dose methotrexate in patients with lymphoma
Rice, Mikhaila , Frazee, Erin N. , Rule, Andrew D. , Martin, Catherine E. , Truong, Huong L. , Mara, Kristin C. , Kashani, Kianoush , Thompson, Carrie A. , Witzig, Thomas E. , Barreto, Jason N. , Witzig, T.E. , Rice, Mikhaila L , Frazee, Erin N , Kashani, Kianoush B , DeFino, Catherine E. , Rule, Andrew D , Mara, Kristin C

Mayo Clinic

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy | November 5, 2023 | Volume: 44 | Issue: 1 | Pages: 4-12

10.1002/phar.2889 | PMID 37926860 Get It

AbstractStudy ObjectiveTo develop and validate a model for predicting acute kidney injury (AKI) after high‐dose methotrexate (HDMTX) exposure.DesignRetrospective analysis.SettingMultisite integrated health system throughout Minnesota and Wisconsin.PatientsAdult patients with lymphoma who received HDMTX as a 4‐h infusion.Measurements and Main ResultsLASSO methodology was used to identify factors available at the outset of therapy that predicted incident AKI within 7 days following HDMTX. The model was then validated in an independent cohort. The incidence of AKI within 7 days following HDMTX was 21.6% (95% confidence interval (CI) 18.4%‐24.8%) in the derivation cohort (435 unique patients who received a total of 1642 doses of HDMTX) and 15.6% (95% CI 5.3%‐24.8%) in the validation cohort (55 unique patients who received a total of 247 doses of HDMTX). Factors significantly associated with AKI after HDMTX in the multivariable model included age ≥ 55 years, male sex, and lower HDMTX dose number. Other factors that were not found to be significantly associated with AKI on multivariable analysis, but were included in the final model, were body surface area, Charlson Comorbidity Index, and estimated glomerular filtration rate. The c‐statistic of the model was 0.72 (95% CI 0.69‐0.75) in the derivation cohort and 0.72 (95% CI 0.60‐0.84) in the validation cohort.ConclusionThis model utilizing identified sociodemographic and clinical factors is predictive of AKI following HDMTX administration in adult patients with lymphoma.
Transarterial Radioembolization: Overview of Radioembolic Devices
Serhal, Muhamad , Gordon, Andrew C. , Toskich, Beau , Lewandowski, Robert J. , Toskich, Beau B. , Brown, Daniel B.

Mayo Clinic

Seminars in Interventional Radiology | November 2, 2023 | Volume: 40 | Issue: 05 | Pages: 461-466

10.1055/s-0043-1772814 | PMID 37927522 Get It

Greater improvement in Neck Disability Index scores in women after surgery for cervical myelopathy: an analysis of the Quality Outcomes Database
Patel, Arati , Umbach, Gray , Chan, Andrew K. , Le, Vivian , Bisson, Erica F. , Bydon, Mohamad , Chou, Dean , Glassman, Steve, Foley, Kevin T. , Shaffrey, Christopher I. , Potts, Eric A. , Shaffrey, Mark E., Coric, Domagoj , Knightly, John J. , Wang, Michael Y. , Fu, Kai-Ming, Slotkin, Jonathan R., Asher, Anthony L. , Virk, Michael S. , Haid, Regis W., Gottfried, Oren N., Meyer, Scott A., Upadhyaya, Cheerag D., Tumialán, Luis M. , Turner, Jay D. , Mummaneni, Praveen V. , Kondapavulur, Sravani , Park, Paul

Mayo Clinic

Neurosurgical Focus | November 1, 2023 | Volume: 55 | Issue: 5 | Pages: E7

10.3171/2023.8.focus23423 | PMID 37913530 Get It

OBJECTIVE There is a high prevalence of cervical myelopathy that requires surgery; as such, it is important to identify how different groups benefit from surgery. The American Association of Neurological Surgeons launched the Quality Outcomes Database (QOD), a prospective longitudinal registry, that includes demographic, clinical, and patient-reported outcome data to measure the safety and quality of neurosurgical procedures. In this study, the authors assessed the impact of gender on patient-reported outcomes in patients who underwent surgery for cervical myelopathy. METHODS The authors analyzed 1152 patients who underwent surgery for cervical myelopathy and were included in the QOD cervical module. Univariate comparison of baseline patient characteristics between males and females who underwent surgery for cervical spondylotic myelopathy was performed. Baseline characteristics that significantly differed between males and females were included in a multivariate generalized linear model comparing baseline and 1-year postoperative Neck Disability Index (NDI) scores. RESULTS This study included 546 females and 604 males. Females demonstrated significantly greater improvement in NDI score 1 year after surgery (p = 0.036). In addition to gender, the presence of axial neck pain and insurance status were also significantly predictive of improvement in NDI score after surgery (p = 0.0013 and p = 0.0058, respectively). CONCLUSIONS Females were more likely to benefit from surgery for cervical myelopathy compared with males. It is important to identify gender differences in postoperative outcomes after surgery in order to deliver more personalized and patient-centric care.